Absolutely Great News, however making my point as to why those can be pivotal but PD isn't. Will be even better news if any of these new trials can get off the ground and start recruiting.
“Both the upcoming FragileX and the Undisclosed disease trials are both expected to be PIVOTAL P2/3 trials, and starting yet this year!”
Most long timers know, this statement means that the trials will start Q2 2022 or later.
We have 2 1/2 months left to submit the protocol - FDA accept it and then start the trial. With Covid delay, getting any protocol approved for new indication will take much more time. So we are unlikely to start the trial before year end.
We will be lucky to get one more result in remaining 2 1/2 months
News 
Market Data 
Discover 
